This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yinhai Wang and Automated Wound-Tissue Assessment.
Introduction
Yinhai Wang is an inventor associated with Cambridge, Great Britain. His patent work includes a method that applies optical coherence tomography and deep learning to assess wound tissue.
Latest Patents
The supplied information identifies one patent for Wang: Automated Assessment of Wound Tissue. The method obtains one or more optical coherence tomography images of a wound and analyzes them with a deep-learning model trained to classify image pixels into classes representing different types of wound tissue. It then indicates where each tissue type is likely located in the images. The record lists 1 patent.
Career Highlights
Wang is associated with AstraZeneca AB. His listed invention brings together medical imaging and machine learning to support the assessment of wounds.
Collaborations
Adrian Mark Freeman is identified as Wang’s coworker. The supplied information does not specify whether Freeman collaborated on the patent.
Conclusion
Yinhai Wang’s listed patent focuses on using optical coherence tomography and deep learning to identify and locate different types of wound tissue, reflecting an application of computational methods to medical assessment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile